ONTOLOGY REPORT - ANNOTATIONS
| Term: | lithium atom |
|
| Accession: | CHEBI:30145
|
browse the term
|
| Definition: | An alkali metal atom that has formula Li. |
| Synonyms: | related_synonym: | 3Li; InChI=1S/Li; InChIKey=WHXSMMKQMYFTQS-UHFFFAOYSA-N; Li; lithium; litio |
| | xref_casrn: | 7439-93-2 |
| | xref_mesh: | MESH:D008094 |
| | xref: | NIST Chemistry WebBook:7439-93-2 "CAS Registry Number"; WebElements:Li "WebElements" |
|
|
lithium atom
|
| G |
Aanat |
aralkylamine N-acetyltransferase |
|
multiple interactions |
EXP |
10 |
106,709,371 |
106,713,683 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
multiple interactions |
EXP |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 homolog (yeast) |
|
increases expression |
EXP |
13 |
37,861,558 |
37,904,589 |
RGD:6480464 |
CTD |
| G |
Adk |
adenosine kinase |
|
increases expression |
EXP |
15 |
3,071,412 |
3,458,891 |
RGD:6480464 |
CTD |
| G |
Adnp2 |
ADNP homeobox 2 |
|
increases expression |
ISO |
18 |
77,017,502 |
77,041,570 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
decreases expression |
EXP |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Antxr2 |
anthrax toxin receptor 2 |
|
increases expression |
ISO |
14 |
12,875,632 |
13,107,975 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
increases expression |
EXP |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
increases expression |
EXP |
19 |
52,854,657 |
52,856,625 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
ISO |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
increases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
decreases expression |
EXP |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Aqp6 |
aquaporin 6, kidney specific |
|
increases expression |
EXP |
7 |
138,347,266 |
138,350,199 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
multiple interactions |
EXP |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
multiple interactions |
EXP |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
multiple interactions |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
increases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
increases expression |
EXP |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
|
increases expression |
EXP |
7 |
11,072,820 |
11,075,906 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
affects expression |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
increases expression |
EXP |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
increases expression |
EXP |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
increases expression |
EXP |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
|
increases expression |
EXP |
12 |
34,907,317 |
34,938,479 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
multiple interactions |
EXP |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
EXP |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
decreases expression |
EXP |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
increases expression |
EXP |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
increases expression |
EXP |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cox5a |
cytochrome c oxidase, subunit Va |
|
increases expression |
EXP |
8 |
61,264,971 |
61,276,380 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
increases expression |
EXP |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Crip1 |
cysteine-rich protein 1 (intestinal) |
|
increases expression |
ISO |
6 |
138,156,366 |
138,161,127 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects localization |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
EXP |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
decreases expression |
ISO |
13 |
85,801,449 |
85,846,636 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
multiple interactions |
EXP |
20 |
29,838,671 |
29,860,514 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
affects response to substance |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
increases response to substance |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
|
increases expression |
EXP |
3 |
145,718,890 |
145,740,187 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
increases expression |
EXP |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Ect2 |
epithelial cell transforming sequence 2 oncogene |
|
increases expression |
EXP |
2 |
112,969,261 |
113,001,056 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
EXP |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
|
increases expression |
EXP |
1 |
84,083,646 |
84,088,799 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
increases expression |
EXP |
1 |
93,820,124 |
93,834,288 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
1 |
78,668,497 |
78,673,330 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
EXP |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA binding protein transcription factor, alpha subunit |
|
multiple interactions |
EXP |
11 |
24,323,963 |
24,352,754 |
RGD:6480464 |
CTD |
| G |
Galm |
galactose mutarotase (aldose 1-epimerase) |
|
decreases expression |
EXP |
6 |
3,024,123 |
3,078,720 |
RGD:6480464 |
CTD |
| G |
Ganab |
glucosidase, alpha; neutral AB |
|
increases expression |
EXP |
1 |
211,573,299 |
211,593,941 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
EXP |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
EXP |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
multiple interactions |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
decreases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
decreases expression |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
multiple interactions |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
multiple interactions |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
decreases expression |
ISO |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
multiple interactions |
EXP |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 |
|
multiple interactions |
EXP |
1 |
80,313,801 |
80,384,390 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
multiple interactions |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
increases expression |
EXP |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
multiple interactions |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
increases expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
multiple interactions |
ISO |
1 |
241,736,542 |
241,742,129 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
affects expression |
ISO |
1 |
241,736,542 |
241,742,129 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet-associated |
|
decreases expression |
ISO |
4 |
56,146,654 |
56,147,441 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Homer3 |
homer homolog 3 (Drosophila) |
|
decreases expression |
ISO |
16 |
19,617,526 |
19,624,915 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases expression |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
EXP |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases expression |
EXP |
X |
41,489,343 |
41,491,788 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
EXP |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
EXP |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
EXP |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
EXP |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
EXP |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
EXP |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impa1 |
Inositol (myo)-1(or 4)-monophosphatase 1 |
|
decreases response to substance |
ISO |
2 |
93,415,958 |
93,438,247 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
increases expression |
EXP |
18 |
27,100,044 |
27,108,530 |
RGD:6480464 |
CTD |
| G |
Kif23 |
kinesin family member 23 |
|
increases expression |
EXP |
8 |
66,050,163 |
66,077,265 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
increases expression |
EXP |
20 |
5,150,810 |
5,169,264 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
affects expression |
ISO |
17 |
75,578,498 |
75,585,072 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A/C |
|
increases expression |
EXP |
2 |
180,595,724 |
180,616,354 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
increases degradation |
ISO |
17 |
61,910,179 |
61,930,459 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions |
ISO |
17 |
61,910,179 |
61,930,459 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases expression |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases expression |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mrpl18 |
mitochondrial ribosomal protein L18 |
|
multiple interactions |
EXP |
1 |
42,111,647 |
42,116,465 |
RGD:6480464 |
CTD |
| G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
|
multiple interactions |
EXP |
4 |
117,321,318 |
117,322,208 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Myl6 |
myosin, light chain 6, alkali, smooth muscle and non-muscle |
|
decreases expression |
EXP |
7 |
1,772,621 |
1,775,663 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases degradation |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
increases expression |
EXP |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
affects response to substance |
ISO |
10 |
87,541,246 |
87,548,186 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nsfl1c |
NSFL1 (p97) cofactor (p47) |
|
increases expression |
EXP |
3 |
141,799,286 |
141,823,762 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
multiple interactions |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
increases expression |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
increases expression |
EXP |
7 |
32,753,728 |
32,769,953 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
decreases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases expression |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases secretion |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
increases expression |
EXP |
X |
88,589,534 |
88,590,947 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp4 |
poly (ADP-ribose) polymerase family, member 4 |
|
increases expression |
ISO |
15 |
35,564,314 |
35,659,367 |
RGD:6480464 |
CTD |
| G |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
|
increases expression |
ISO |
1 |
2,287,981 |
2,304,638 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
increases expression |
EXP |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
decreases expression |
EXP |
8 |
20,192,677 |
20,241,557 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
EXP |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde8b |
phosphodiesterase 8B |
|
decreases expression |
EXP |
2 |
25,352,725 |
25,469,209 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
increases expression |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
increases expression |
EXP |
12 |
40,491,393 |
40,495,593 |
RGD:6480464 |
CTD |
| G |
Pex1 |
peroxisomal biogenesis factor 1 |
|
increases expression |
ISO |
4 |
27,235,147 |
27,275,076 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pls3 |
plastin 3 |
|
increases expression |
EXP |
X |
29,868,937 |
29,965,118 |
RGD:6480464 |
CTD |
| G |
Ppia |
peptidylprolyl isomerase A (cyclophilin A) |
|
increases expression |
EXP |
14 |
87,165,998 |
87,169,995 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
increases expression |
EXP |
1 |
209,583,414 |
209,586,399 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
multiple interactions |
ISO |
1 |
64,145,749 |
64,172,712 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
increases expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
|
increases expression |
EXP |
20 |
4,801,187 |
4,806,608 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
decreases expression |
ISO |
9 |
84,807,822 |
84,882,942 |
RGD:6480464 |
CTD |
| G |
Psmd13 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 |
|
increases expression |
EXP |
1 |
201,044,403 |
201,057,026 |
RGD:6480464 |
CTD |
| G |
Psmd8 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
increases expression |
EXP |
1 |
84,308,348 |
84,315,180 |
RGD:6480464 |
CTD |
| G |
Psme2 |
proteasome (prosome, macropain) activator subunit 2 |
|
increases expression |
EXP |
15 |
33,722,370 |
33,726,669 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
EXP |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
multiple interactions |
EXP |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Qars |
glutaminyl-tRNA synthetase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
increases expression |
EXP |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rad18 |
RAD18 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
148,452,664 |
148,543,743 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
increases expression |
EXP |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Rel |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
14 |
104,645,370 |
104,671,275 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
EXP |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
multiple interactions |
EXP |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
increases expression |
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rnmt |
RNA (guanine-7-) methyltransferase |
|
increases expression |
ISO |
18 |
64,690,985 |
64,711,525 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
decreases expression |
EXP |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
decreases expression |
EXP |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions |
ISO |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1, beta |
|
multiple interactions |
ISO |
1 |
180,682,622 |
180,748,068 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1, gamma |
|
multiple interactions |
ISO |
1 |
180,555,660 |
180,589,534 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1, gamma |
|
affects expression |
EXP |
1 |
180,555,660 |
180,589,534 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
increases expression |
EXP |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
increases expression |
EXP |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
increases expression |
EXP |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
ISO |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
ISO |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
EXP |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
|
increases expression |
ISO |
1 |
101,425,975 |
101,466,023 |
RGD:6480464 |
CTD |
| G |
Slc17a7 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
|
increases expression |
ISO |
1 |
95,640,743 |
95,651,938 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
multiple interactions |
ISO |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
increases activity |
ISO |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
decreases expression |
ISO |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Slc9a3 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
|
increases expression |
EXP |
1 |
29,930,908 |
29,973,686 |
RGD:6480464 |
CTD |
| G |
Slc9b2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
|
multiple interactions |
ISO |
2 |
232,789,603 |
232,833,880 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slit2 |
slit homolog 2 (Drosophila) |
|
increases expression |
EXP |
14 |
67,546,283 |
67,891,840 |
RGD:6480464 |
CTD |
| G |
Slit2 |
slit homolog 2 (Drosophila) |
|
decreases expression |
EXP |
14 |
67,546,283 |
67,891,840 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sparcl1 |
SPARC-like 1 (hevin) |
|
affects localization |
EXP |
14 |
6,766,347 |
6,797,581 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
EXP |
3 |
51,361,185 |
51,374,357 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Srcin1 |
SRC kinase signaling inhibitor 1 |
|
increases expression |
EXP |
10 |
86,263,255 |
86,320,681 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
decreases expression |
ISO |
10 |
16,514,603 |
16,524,369 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
increases expression |
EXP |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
increases expression |
EXP |
16 |
5,908,759 |
5,933,695 |
RGD:6480464 |
CTD |
| G |
Tmx4 |
thioredoxin-related transmembrane protein 4 |
|
increases expression |
EXP |
3 |
122,591,543 |
122,634,935 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
increases expression |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
decreases expression |
EXP |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
increases expression |
EXP |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
EXP |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Uck1 |
uridine-cytidine kinase 1 |
|
increases expression |
EXP |
3 |
11,366,634 |
11,372,517 |
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Uqcrfs1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
|
increases expression |
EXP |
17 |
40,429,806 |
40,434,083 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vps29 |
vacuolar protein sorting 29 homolog (S. cerevisiae) |
|
increases expression |
EXP |
12 |
35,403,351 |
35,412,395 |
RGD:6480464 |
CTD |
| G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
increases expression |
EXP |
10 |
63,072,128 |
63,109,833 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
decreases expression |
EXP |
6 |
41,945,769 |
41,976,123 |
RGD:6480464 |
CTD |
lithium carbonate
|
| G |
Alad |
aminolevulinate dehydratase |
|
multiple interactions |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
decreases activity |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
lithium chloride
|
| G |
Abat |
4-aminobutyrate aminotransferase |
|
decreases expression |
ISO |
10 |
7,040,725 |
7,137,154 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
decreases expression |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
increases activity |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Amy1a |
amylase, alpha 1A (salivary) |
|
multiple interactions |
EXP |
2 |
209,548,721 |
209,563,532 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
ISO |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
ISO |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
decreases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
ISO |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
increases expression |
ISO |
2 |
218,619,428 |
218,679,087 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atp5i |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E |
|
decreases expression |
ISO |
14 |
1,867,344 |
1,868,472 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
multiple interactions |
ISO |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
increases expression |
ISO |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
increases expression |
ISO |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Bai3 |
brain-specific angiogenesis inhibitor 3 |
|
increases expression |
ISO |
9 |
23,759,340 |
24,495,409 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
increases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
increases expression |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects localization |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases phosphorylation |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
decreases expression |
ISO |
14 |
16,338,132 |
16,346,628 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
14 |
16,338,132 |
16,346,628 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression |
EXP |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
EXP |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
increases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
multiple interactions |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
increases expression |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
increases expression |
ISO |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Clk2 |
CDC-like kinase 2 |
|
decreases expression |
ISO |
2 |
181,244,665 |
181,257,364 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases expression |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crisp2 |
cysteine-rich secretory protein 2 |
|
decreases expression |
ISO |
9 |
16,247,687 |
16,271,947 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor (zinc finger protein) |
|
increases expression |
EXP |
19 |
35,461,942 |
35,514,934 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases phosphorylation |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases activity |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases localization |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases activity |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects localization |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases activity |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Efna3 |
ephrin A3 |
|
decreases expression |
EXP |
2 |
181,454,410 |
181,508,170 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Epha5 |
EPH receptor A5 |
|
decreases expression |
EXP |
14 |
25,524,170 |
25,896,798 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
decreases expression |
ISO |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fzd3 |
frizzled family receptor 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fzd4 |
frizzled family receptor 4 |
|
increases expression |
ISO |
1 |
145,953,743 |
145,957,666 |
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled family receptor 6 |
|
increases expression |
ISO |
7 |
74,562,307 |
74,594,014 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
increases expression |
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
multiple interactions |
ISO |
10 |
84,732,705 |
84,740,801 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
increases expression |
ISO |
10 |
84,732,705 |
84,740,801 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects localization |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
ISO |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
ISO |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases stability |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases expression |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
affects phosphorylation |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdgfrp3 |
hepatoma-derived growth factor, related protein 3 |
|
decreases expression |
ISO |
1 |
138,098,818 |
138,130,696 |
RGD:6480464 |
CTD |
| G |
Hist1h2bl |
histone cluster 1, H2bl |
|
decreases expression |
ISO |
17 |
50,343,037 |
50,343,698 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin-binding sialoprotein |
|
decreases expression |
ISO |
14 |
6,548,541 |
6,561,165 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
decreases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Itgb8 |
integrin, beta 8 |
|
increases expression |
ISO |
6 |
146,494,978 |
146,573,064 |
RGD:6480464 |
CTD |
| G |
Krt34 |
keratin 34 |
|
increases expression |
ISO |
10 |
88,973,452 |
88,977,141 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
multiple interactions |
ISO |
2 |
228,550,263 |
228,673,131 |
RGD:6480464 |
CTD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
increases expression |
EXP |
16 |
84,881,880 |
84,888,448 |
RGD:6480464 |
CTD |
| G |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
|
increases expression |
ISO |
4 |
171,337,114 |
171,444,932 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
affects phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
decreases expression |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
decreases expression |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
decreases expression |
ISO |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
decreases expression |
ISO |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
decreases expression |
ISO |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mrpl47 |
mitochondrial ribosomal protein L47 |
|
decreases expression |
ISO |
2 |
118,935,032 |
118,946,172 |
RGD:6480464 |
CTD |
| G |
Msi1 |
musashi RNA-binding protein 1 |
|
increases expression |
ISO |
12 |
42,425,957 |
42,462,517 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myh4 |
myosin, heavy chain 4, skeletal muscle |
|
multiple interactions |
ISO |
10 |
53,931,880 |
53,955,029 |
RGD:6480464 |
CTD |
| G |
Myh4 |
myosin, heavy chain 4, skeletal muscle |
|
increases expression |
ISO |
10 |
53,931,880 |
53,955,029 |
RGD:6480464 |
CTD |
| G |
Myh8 |
myosin, heavy chain 8, skeletal muscle, perinatal |
|
increases expression |
ISO |
10 |
53,973,711 |
54,002,442 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
increases expression |
ISO |
4 |
159,190,786 |
159,198,160 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
multiple interactions |
ISO |
4 |
159,190,786 |
159,198,160 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
increases activity |
ISO |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
decreases expression |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pax3 |
paired box 3 |
|
increases expression |
ISO |
9 |
77,477,813 |
77,576,632 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdlim5 |
PDZ and LIM domain 5 |
|
increases expression |
ISO |
2 |
240,177,301 |
240,304,192 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
multiple interactions |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
affects response to substance |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
increases response to substance |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
|
increases expression |
ISO |
12 |
45,386,041 |
45,434,744 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
decreases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
increases expression |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Prr16 |
proline rich 16 |
|
decreases expression |
ISO |
18 |
46,322,191 |
46,534,140 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
increases expression |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
increases expression |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
11 |
32,386,576 |
32,408,850 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
increases expression |
ISO |
13 |
85,533,882 |
85,540,173 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
increases expression |
ISO |
3 |
32,101,433 |
32,118,785 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
increases expression |
ISO |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
Scn5a |
sodium channel, voltage-gated, type V, alpha subunit |
|
decreases activity |
ISO |
8 |
124,446,479 |
124,545,301 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
decreases expression |
ISO |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
multiple interactions |
ISO |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Six1 |
SIX homeobox 1 |
|
increases expression |
ISO |
6 |
95,470,153 |
95,475,389 |
RGD:6480464 |
CTD |
| G |
Six1 |
SIX homeobox 1 |
|
increases response to substance |
ISO |
6 |
95,470,153 |
95,475,389 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
decreases expression |
ISO |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
multiple interactions |
ISO |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
increases expression |
ISO |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
ISO |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc5a3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
|
increases expression |
ISO |
11 |
32,063,275 |
32,065,721 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
decreases degradation |
ISO |
3 |
158,676,980 |
158,681,471 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
3 |
158,676,980 |
158,681,471 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
3 |
158,676,980 |
158,681,471 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Stard7 |
StAR-related lipid transfer (START) domain containing 7 |
|
multiple interactions |
ISO |
3 |
114,768,201 |
114,795,440 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Tars |
threonyl-tRNA synthetase |
|
increases expression |
ISO |
2 |
60,765,899 |
60,784,665 |
RGD:6480464 |
CTD |
| G |
Tbc1d8 |
TBC1 domain family, member 8 |
|
decreases expression |
ISO |
9 |
38,443,425 |
38,554,183 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
multiple interactions |
ISO |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
multiple interactions |
ISO |
1 |
262,031,823 |
262,226,710 |
RGD:6480464 |
CTD |
| G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
|
increases expression |
ISO |
2 |
146,521,188 |
146,530,382 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
decreases expression |
EXP |
7 |
54,321,033 |
54,430,706 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
decreases expression |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
increases expression |
EXP |
2 |
19,904,490 |
20,158,358 |
RGD:6480464 |
CTD |
| G |
Yes1 |
Yamaguchi sarcoma viral (v-yes) oncogene homolog 1 |
|
multiple interactions |
ISO |
9 |
112,516,831 |
112,564,072 |
RGD:6480464 |
CTD |
| G |
Zfp207 |
zinc finger protein 207 |
|
increases expression |
ISO |
10 |
68,613,434 |
68,625,197 |
RGD:6480464 |
CTD |
| G |
Zmynd8 |
zinc finger, MYND-type containing 8 |
|
decreases expression |
ISO |
3 |
156,860,459 |
156,957,748 |
RGD:6480464 |
CTD |
Term paths to the root
|